Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in the number of shares in Humana AB and reduction of holding of own shares

As previously communicated, the Annual General Meeting decided on May 10, 2022, to redeem 5,314,006 own shares that had been repurchased through previous repurchase authorisations, and to increase share capital through a bonus issue. After registration at the Swedish Companies Registration Office (Bolagsverket), on May 17, 2022, the decisions have now been executed. The share capital is unchanged and amounts to SEK 1,180,890.32. After the redemption, the total number of shares and votes in Humana AB amounts to 47,826,058. The redeemed shares represented approximately10 percent of the

Toivo Group Oyj - Managers' Transactions - Asko Myllymäki

Toivo Group Oyj - Managers' Transactions - 19 May 2022 at 3:30 p.m. Person subject to the notification requirement Name: Sirkka Myllymäki Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Asko Myllymäki Position: Member of the Board Issuer: Toivo Group Oyj LEI: 743700N31WYJDNPT8M98 Notification type: INITIAL NOTIFICATION Reference number: 15295/4/4 ____________________________________________ Transaction date: 2022-05-17 Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME) Instrument type: SHARE

Calliditas receives positive CHMP opinion in IgA nephropathy

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the granting of a conditional marketing authorisation for Kinpeygo[TM] for the treatment of primary immunoglobulin A (IgA) nephropathy (IgAN) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/gram. If confirmed by the European Commission (EC), Kinpeygo will be the first and only approved treatment for IgAN,

COMMUNIQUE FROM THE ANNUAL GENERAL MEETING OF STENOCARE

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENOOn 19 May 2022 annual general meeting of shareholders of STENOCARE A/S, CVR no. 39024705, was held at St. Kannikestræde 19, 1169 Copenhagen K with the following agenda: Agenda: 1. Appointment of a chairman of the meeting 2. Report of the chairman of the board of directors 3. Presentation of the annual report together with a resolution for its adoption 4. Resolution to appropriate the profit or cover the loss 5. Election of members of the board of directors 6. Appointment of an auditor 7. Authorisation

Audientes A/S intends to carry out a listing change to Spotlight Stock Market Denmark

The Board of Directors of Audientes A/S ("Audientes" or "the Company") hereby convenes an Extraordinary General Meeting to decide on a proposed listing change from Nasdaq First North Growth Market Denmark to Spotlight Stock Market Denmark.The upcoming Extraordinary General Meeting will decide whether to apply for admission for trading on Spotlight Stock Market Denmark ("Spotlight") in Danish kroner, and delist the Company’s shares from Nasdaq First North Growth Market in Copenhagen (“First North”). Change of marketplace to increase visibility and liquidity Audientes is an

Invitation to Alleima Capital Markets Day on August 23, 2022

Alleima (former business area Sandvik Materials Technology) has the pleasure of inviting institutional investors, analysts, and financial media to its first Capital Markets Day. Alleima is the onging spin-off from Sandvik AB with expected listing on Nasdaq Stockholm on August 31, 2022. The Capital Markets Day will be hosted at the industrial site in Sandviken, Sweden on August 23, 2022. Presentations will be held by the executive management team and provide an in-depth overview of the strategic direction, product offering, key customer segments, and financial targets of Alleima as a

First patient enrolled in Diamyd Medical's Phase III trial DIAGNODE-3

The first patient has now received its first intralymphatic injection of Diamyd[®] in the precision medicine Phase III trial DIAGNODE-3. The trial will include approximately 330 patients aged 12 to 29 years newly diagnosed with Type 1 Diabetes who carry the genetically defined haplotype HLA DR3-DQ2.“The fact that the first patient is now enrolled in DIAGNODE-3 is a major milestone for the therapeutic diabetes vaccine Diamyd," says Ulf Hannelius, CEO of Diamyd Medical. “The Phase III trial is based on decisive scientific achievements in precision medicine, robust data, a unique and safe

Latour Capital Markets Day 2022

Today at 14.00, Investment AB Latour organizes a Capital Markets Day where analysts, investors, representatives of the banking and financial sector and media are invited. The event takes place at Stockholm Waterfront Congress Centre. All presentations will be published on Latour’s website, www.latour.se. Göteborg May 19, 2022 INVESTMENT AB LATOUR (PUBL)Johan Hjertonsson, President and CEO For more information, please contact:Johan Hjertonsson, CEO Latour +46 8 679 56 00 Investment AB Latour is a mixed investment company consisting primarily of a wholly-owned industrial

Scania appoints Jeanna Tällberg as Head of People & Culture and member of Scania Executive Board

Jeanna Tällberg has been appointed Executive Vice President and Head of People & Culture as from 1 October 2022, and will report to Christian Levin, President and CEO.Jeanna Tällberg leaves H&M Group where she has been Head of HR Business Tech. She is familiar with Scania, as she had a career at the company, starting 2003 as HR Business Partner, and continued with various roles in HR. Later she became Director of Leadership and Organisational Development, a position she held from 2012 to 2015. Jeanna Tällberg has also been HR Director for Volkswagen Group Sverige as well as Executive Vice

Ahlstrom-Munksjö launches PurposeSeal™ heat seal technology

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE MAY 19, 2022 at 15:00 EEST Ahlstrom-Munksjö has pledged to create sustainable, fiber-based solutions. PurposeSeal™ is pushing the boundaries of fiber-based end-use applications.   PurposeSeal™ is a heat-sealed paper carefully constructed to ensure quality and protection for end-use packaging solutions. It boasts additional sustainability benefits when applied to Cristal™ Transparent Packaging Papers or trulyNatural™ unbleached papers. Ahlstrom-Munksjö recently received recyclability certification for the Cristal™ transparent paper product family,

SBB and K2A secure major rental agreements with the Swedish Police Authority and the Swedish Prison and Probation Service

Samhällsbyggnadsbolaget i Norden AB (“SBB”) and K2A Knaust & Andersson Fastigheter AB (“K2A”) have jointly signed rental agreements with the Swedish Police Authority and the Swedish Prison and Probation Service to let a total of approximately 42,500 square metres of space in Västerås. The total annual rental value of the agreements is just over SEK 95m with a contract term of 20 years. Construction of the property is scheduled to begin in 2023 and occupancy is planned for 2026. Taken together, the agreements are the largest office letting in Sweden since 2019 and one of the five largest

K2A and SBB secure major rental agreements with the Police Authority and the Prison and Probation Service

K2A Knaust & Andersson Fastigheter AB and Samhällsbyggnadsbolaget i Norden AB (SBB)  have jointly signed rental agreements with the Swedish Police Authority and the Swedish Prison and Probation Service to let a total of approximately 42,500 square metres of space in Västerås. The total annual rental value of the agreements is over SEK 95 million with a contract term of 20 years.Construction of the property is scheduled to begin in 2023 and occupancy is planned for 2026. Taken together, the agreements are the largest office letting in Sweden since 2019 and one of the five largest lettings

Interim Report January – March 2022

Continued strong growth Quarterly net sales increased by 85 percent, with a strong contribution from the Norrvidinge acquisition. High market demand, but a global pandemic and the war in Ukraine have resulted in large price increases in fuels and raw materials, which has led to lower margins. Cash flow from operating activities improved during the quarter. The acquisition strategy remains firm, focusing on identified growth region in Sweden.“We live in a troubled world. A global pandemic has been accompanied by the war in Ukraine with major humanitarian consequences. This has reinforced

Swedish Government grants permit for offshore wind farm Kriegers Flak

Vattenfall welcomes the Swedish Government’s decision to grant construction permit of an offshore wind farm at Swedish Kriegers Flak.Kriegers Flak in the south of the Baltic sea is the one of Vattenfall’s Swedish offshore wind projects that has come the furthest in its development. Vattenfall’s application covers 40 to 50 wind turbines with a total capacity of approximately 640 MW. Annual production would be sufficient to charge one million electric cars per year or to meet the annual needs of just over a half a million households. “We are happy that the Government has made this decision.

Proact retains top ranking in major customer satisfaction survey

With the most challenging phase of the Covid-19 pandemic now over, customer satisfaction in the Swedish IT market is rising, according to industry analysts Radar. In Radar’s newly released 2022 Supplier Quality survey, Proact retains its top ranking in two of the market segments where customer satisfaction was evaluated.The independent analyst firm Radar Ecosystem Specialists has just released its 2022 Supplier Quality report, which measures quality and value creation in customer-supplier relationships in the Swedish IT market. Decision makers from more than 800 organisations have

Plant breeding of oats is taking new leaps

Researchers at Lantmännen's research company CropTailor and at ScanOats in Lund have sequenced the entire genome of oats. This opens new opportunities for developing oats that are healthier and that can be grown in a more sustainable way.Lantmännen-owned research company CropTailor has, together with researchers from ScanOats at Lund University, mapped and characterized oats and their entire genome. The results are now published in the highly reputable journal Nature and can be downloaded here [link ]. "Lantmännen already has a very

Profitability improving, outlook remains positive

Delete Group Oyj  Stock exchange release             19 May 2022 at 2:00 p.m. EEST   DELETE GROUP OYJ   Interim Review January–March 2022 (IFRS, unaudited)   PROFITABILITY IMPROVING, OUTLOOK REMAINS POSITIVE     KEY POINTS: JANUARY–MARCH 2022   •         Net sales decreased by 7% to EUR 21.0 (Q1 2021: 22.6) million due to divestment of W-Tech Entreprenad AB. Organic growth was +3% •         EBITDA increased by EUR 1.0 million to EUR 0.2 (-0.8) million •         EBIT increased by EUR 1.0 million to EUR -3.0 (-4.0) million •         Operative cash

Report from the Annual General Meeting of ChromoGenics AB on 19 May 2022

The annual general meeting of shareholders of ChromoGenics AB was held today on 19 May 2022. The annual general meeting adopted, inter alia, the following resolutions.Balance sheets and income statements The annual general meeting adopted the company’s balance sheet and income statement for the financial year 2021. Disposition regarding the company’s results The annual general meeting resolved, pursuant to the proposal of the board, that the company’s results be carried forward. Discharge from liability The annual general meeting discharged the board members and the managing

Teknos receives EcoVadis gold medal for sustainability performance, ranking top 5% among companies globally

Teknos has been granted the EcoVadis gold medal for its sustainability performance in 2021. This places Teknos within the top 5% of 90,000 companies that are rated by EcoVadis across the globe. Over 90,000 companies in over 160 countries have already been assessed on the EcoVadis’ platform. In EcoVadis  companies are assessed based on four categories: Environment, Labour and Human Rights, Ethics, and Sustainable Procurement. Teknos performed best in the Environmental part with a score of 80/100 and reached a good level also in Labor and Human Rights and Sustainable

Implantation with clinical version rescheduled for change of animal

Press release, 19 May 2022 Realheart is conducting a series of implantations in sheep this spring to test the newly developed clinical version of its artificial heart. However, in preparation for the first surgery, it was discovered that the sheep made available at the lab did was not suitable for the surgery. The first surgery was therefore postponed until early June to prepare a new animal.The clinical version of the Realheart® TAH – the version that will eventually be used in humans – is now at the animal lab in Belgium where it is undergoing sterilisation pending surgery. It was

Noreco – Minutes from Annual General Meeting

Oslo, 19 May 2022: Norwegian Energy Company ASA (“Noreco” or the "Company") has today held its annual general meeting (“AGM”) digitally through the solution Lumi AGM. Minutes from the AGM will be made available on the Company's website: www.noreco.com This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.  *** Contact: Cathrine Torgersen, EVP Investor Relations & ESGEmail: ct@noreco.comPhone: +47 915 28 501

Calmark compliant with IVDR from today

Anna Söderlund, CEO of Calmark Sweden AB (publ) has today signed the ‘Declaration of Conformity’ showing that Calmark has adapted the quality system and the technical documentation to comply with the new IVDR regulations. The documentation will now be sent to the Swedish Medical Products Agency. Compliance with the IVDR is a requirement to maintain the CE marking of existing products from May 26, 2022 onwards."It has been extensive work to adapt our operations and our entire quality system to comply with the new regulations," says Anna Söderlund, CEO of Calmark. "I am very proud that we

SOFTSWISS Sportsbook Launches New Multi-Brand Back Office

The SOFTSWISS Sportsbook enhances the capabilities of its clients by upgrading the product’s back office. The new functionality allows operators to manage the betting process more effectively, as well as collect information about the results of different projects in one place.Among the top 3 novelties, the Sportsbook team highlights the following: 1.Full real-time statistics  2.Rich bonus customisation opportunities 3.Multi-brand management: clients have access to all projects and data related to them via one back office All Sportsbook 

There are no items matching the current filter
There are no more items matching the current filter
Back to top